Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Mesothelioma, Malignant × Pemetrexed × Clear all

Phase

Phase 2 21 Phase 1 11 Phase 1/2 6 Phase 3 4 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 11 Lung Neoplasms 5 Mesothelioma 3 NSCLC 2 Recurrence 1 Nonsquamous Non-small Cell Lung Cancer 1 Non-squamous Non-small Cell Lung Cancer 1 Neoplasms 1 Mesothelioma, Malignant 1 Adenocarcinoma of Lung 1

Interventions

Pemetrexed 1 Cisplatin 1 Carboplatin 1 ADI PEG20 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02709512 2023-10-04

ATOMIC

Polaris Group

Phase 2/3 Completed

249 enrolled 17 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡